Loubieres Charlotte, Hans Stéphane, Lechien Jerome R, Ansarin Mohssen, Atallah Sarah, Barbut Jonathan, Bizeau Alain, Burkey Brian, Céruse Philippe, Choussy Olivier, Couineau Florent, De Mones Del Pujol Erwan, Dolivet Gilles, Fakhry Nicolas, Garrel Renaud, Giger Roland, Golusiński Wojciech, Gorphe Philippe, Lorentz Clémence, Malard Olivier, Meccariello Giuseppe, Morinière Sylvain, Pellini Raul, Saroul Nicolas, Tagliabue Marta, Vergez Sebastien, Vilaseca Isabel, Villeneuve Alexandre, Baudouin Robin
Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, Suresnes, France.
School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Montigny-le-Bretonneux, France.
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):907-917. doi: 10.1007/s00405-024-09070-5. Epub 2024 Nov 28.
To assess the opinion, practices, and challenges of international key opinion leaders about two minimal invasive surgical techniques in supraglottic laryngeal tumours: transoral laser microsurgery (TLM) and the transoral robotic surgery (TORS).
Design of a questionnaire composed of seven sections and fifty questions covering descriptive data of participants, practitioners experience procedural sequences, considerations related to airways, feeding, and voice, intraoperative haemorrhage, postoperative management, and a comparative analysis of TLM and TORS in treating supraglottic laryngeal cancer.
A total of 27 head and neck surgeons replied to the survey. The experts had an average experience in laryngeal surgery of 20.0 ± 9.4 years, ranging from 5 to 36 years. We noted a significantly shorter installation time in TLM compared to TORS (19% of experts estimated the installation time of over 20 min with TLM vs 44% with TORS; p = 0.02). According to complications, the experts considered that bleeding was the major concern with supraglottic laryngeal surgery, especially intraoperative bleeding in TLM (52% in TLM vs 26% in TORS) (p = 0.09) and postoperative bleeding in TORS (56% in TORS vs 44% in TLM).
The experts did not identify a clear superiority of one technology (TLM) over the other (TORS). The two techniques seemed equivalent to the experts, except for the control of intraoperative haemostasis and visualisation of the surgical field, where TORS was perceived as superior to TLM.
评估国际主要意见领袖对声门上喉肿瘤的两种微创手术技术的看法、实践经验及面临的挑战,这两种技术分别是经口激光显微手术(TLM)和经口机器人手术(TORS)。
设计一份问卷,问卷由七个部分和五十个问题组成,内容涵盖参与者的描述性数据、从业者的手术经验、手术步骤、与气道、进食及发声相关的考量、术中出血、术后管理,以及TLM和TORS治疗声门上喉癌的对比分析。
共有27位头颈外科医生回复了该调查。专家们的喉手术平均经验为20.0±9.4年,范围从5年至36年。我们注意到,与TORS相比,TLM的设备安装时间明显更短(19%的专家估计TLM的设备安装时间超过20分钟,而TORS为44%;p = 0.02)。就并发症而言,专家们认为出血是声门上喉手术的主要问题,尤其是TLM的术中出血(TLM为52%,TORS为26%)(p = 0.09)以及TORS的术后出血(TORS为56%,TLM为44%)。
专家们并未确定一种技术(TLM)相对于另一种技术(TORS)具有明显优势。除了术中止血控制和手术视野可视化方面,专家们认为这两种技术似乎相当,在这两方面TORS被认为优于TLM。